Data for Biomarkers of NAFLD progression: a lipidomics approach to an epidemic. Part 3:Urine (Study ST000917)
(Analysis AN001499)Values for each metabolite have been scaled by dividing by the mean across all factors Run Hierarchial cluster analysis on this study | Run Heatmap cluster analysis on this studyMetabolite | F1 | F2 | F3 | F4 |
---|---|---|---|---|
CoQ-10 | 1.3988 | 1.0688 | 0.7793 | 0.8435 |
CoQ-9 | 1.1888 | 0.9863 | 0.7582 | 1.2200 |
Dolichol-17 | 0.7272 | 0.7975 | 0.6069 | 2.2249 |
Dolichol-18 | 1.0250 | 1.0001 | 0.8114 | 1.3047 |
Dolichol-19 | 0.9752 | 1.0681 | 0.8345 | 1.2436 |
Dolichol-20 | 0.9185 | 1.1601 | 0.8177 | 1.2339 |
Factors:
F1 | Diagnosis:Cirrhosis |
F2 | Diagnosis:NASH |
F3 | Diagnosis:Normal |
F4 | Diagnosis:Steatosis |